71 related articles for article (PubMed ID: 6252506)
1. ATR-101, a selective ACAT1 inhibitor, decreases ACTH-stimulated cortisol concentrations in dogs with naturally occurring Cushing's syndrome.
Langlois DK; Fritz MC; Schall WD; Bari Olivier N; Smedley RC; Pearson PG; Bailie MB; Hunt SW
BMC Endocr Disord; 2018 May; 18(1):24. PubMed ID: 29720169
[TBL] [Abstract][Full Text] [Related]
2. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
Perosevic M; Tritos NA
Drug Des Devel Ther; 2023; 17():1303-1312. PubMed ID: 37143705
[TBL] [Abstract][Full Text] [Related]
3. Osilodrostat in Cushing's disease: the management of its efficacy and the pitfalls of post-surgical results.
Antonini S; Brunetti A; Zampetti B; Boeris D; Saladino A; Cesare Cozzi R
Endocrinol Diabetes Metab Case Rep; 2022 Nov; 2022():. PubMed ID: 36515363
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypertension secondary to high endogenous steroid load in Cushing's disease.
Habib SN; Lin Z; Puvanachandra N
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30635306
[TBL] [Abstract][Full Text] [Related]
5. Cushing's syndrome in childhood: update on genetics, treatment, and outcomes.
Lodish M
Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):48-54. PubMed ID: 25517021
[TBL] [Abstract][Full Text] [Related]
6. Prolonged adrenal insufficiency following discontinuation of osilodrostat treatment for intense hypercortisolism.
Ferriere A; Salenave S; Puerto M; Young J; Tabarin A
Eur J Endocrinol; 2024 Jan; 190(1):L1-L3. PubMed ID: 38123490
[TBL] [Abstract][Full Text] [Related]
7. Case report: Patient presenting with Cushing's disease.
Shaver D
Surg Neurol Int; 2015; 6(Suppl 6):S268-70. PubMed ID: 26069847
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of Cushing's disease: Overview and recent findings.
Praw SS; Heaney AP
Int J Gen Med; 2009 Dec; 2():209-17. PubMed ID: 20360906
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.
Nieman LK; Biller BM; Findling JW; Murad MH; Newell-Price J; Savage MO; Tabarin A;
J Clin Endocrinol Metab; 2015 Aug; 100(8):2807-31. PubMed ID: 26222757
[TBL] [Abstract][Full Text] [Related]
10. THE OCCURRENCE OF SUBACUTE THYROIDITIS AFTER THE AMELIORATION OF HYPERCORTISOLISM FOLLOWING TRANSSPHENOIDAL SURGERY IN CUSHING'S DISEASE.
Sencar E; Calapkulu M; Sakız D; Unsal I; Bostan H; Cakal E
Acta Endocrinol (Buchar); 2023; 19(2):249-251. PubMed ID: 37908880
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcome of trans-sphenoidal approach to pituitary adenoma in adult patients: 10 years experience in northwest of Iran.
Salehpoor F; Kamalifar A; Mirzaii F; Aghazadeh J; Mousavi Aghdas M; Kamalifar S; Bagheri A; Hamadani H
Med J Islam Repub Iran; 2021; 35():88. PubMed ID: 34291012
[No Abstract] [Full Text] [Related]
12. Cushing's pituitary basophilism treated successfully by deep x-ray therapy.
Ellman P; Vilvandré G
Proc R Soc Med; 1946 Jul; 39(9):516. PubMed ID: 19993343
[No Abstract] [Full Text] [Related]
13. Author Correction: Identification of recurrent USP48 and BRAF mutations in Cushing's disease.
Chen J; Jian X; Deng S; Ma Z; Shou X; Shen Y; Zhang Q; Song Z; Li Z; Peng H; Peng C; Chen M; Luo C; Zhao D; Ye Z; Shen M; Zhang Y; Zhou J; Fahira A; Wang Y; Li S; Zhang Z; Ye H; Li Y; Shen J; Chen H; Tang F; Yao Z; Shi Z; Chen C; Xie L; Wang Y; Fu C; Mao Y; Zhou L; Gao D; Yan H; Zhao Y; Huang C; Shi Y
Nat Commun; 2023 Aug; 14(1):5128. PubMed ID: 37612270
[No Abstract] [Full Text] [Related]
14. Recurrent Cushing's disease: successful treatment by pituitary irradiation or trans-sphenoidal hypophysectomy in two cases.
Caplan RH; Annis BL
Neurosurgery; 1980 Aug; 7(2):160-5. PubMed ID: 6252506
[TBL] [Abstract][Full Text] [Related]
15. [Transsphenoidal hypophysectomy of a patient with an ACTH-producing pituitary adenoma and an "empty sella" after pretreatment with etomidate].
Herrmann BL; Mitchell A; Saller B; Stolke D; Forsting M; Frilling A; Mann K
Dtsch Med Wochenschr; 2001 Mar; 126(9):232-4. PubMed ID: 11256037
[TBL] [Abstract][Full Text] [Related]
16. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
17. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
18. Extrapituitary parasellar microadenoma in Cushing's disease.
Pluta RM; Nieman L; Doppman JL; Watson JC; Tresser N; Katz DA; Oldfield EH
J Clin Endocrinol Metab; 1999 Aug; 84(8):2912-23. PubMed ID: 10443699
[TBL] [Abstract][Full Text] [Related]
19. Unpredictable hypersecretion of cortisol in Cushing's disease: detection by daily salivary cortisol measurements.
Hermus AR; Pieters GF; Borm GF; Verhofstad AA; Smals AG; Benraad TJ; Kloppenborg PW
Acta Endocrinol (Copenh); 1993 May; 128(5):428-32. PubMed ID: 8391195
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
